Rchr
J-GLOBAL ID:200901043815942298   Update date: Jan. 30, 2024

Sato Ken

Sato Ken | Sato Ken
Affiliation and department:
Job title: Associate Professor
Research field  (1): Gastroenterology
Research keywords  (10): microPIXE ,  ファージディスプレイ ,  微量金属 ,  ウイルス肝炎 ,  非アルコール性脂肪肝炎 ,  microPIXE ,  phage display ,  trace metals ,  viral hepatitis ,  nonalcoholic steatohepatitis
Research theme for competitive and other funds  (5):
  • 2022 - 2025 Galectin 3阻害剤創薬による難治疾患の病態解明と治療応用を目指した研究
  • 2020 - 2023 転写共役活性化因子PDIP1による普遍的酸化ストレス調節能の検証と標的分子探索
  • 2014 - 2018 The role of a transcriptional coactivator (PDIP1) that functions as a transcriptional coregulator of several nuclear receptors in the physiopathological process of the liver
  • 2011 - 2013 The role of nuclear receptor coactivator PDIP1 in non-alcholic steatohepatitis
  • 2008 - 2010 The role of endoplasmic reticulum (ER) stress in non-alcoholic steatohepatitis
Papers (320):
  • Ryosuke Nakamura, Noriaki Arakawa, Yoichi Tanaka, Nahoko Uchiyama, Akihiro Sekine, Yoichi Mashimo, Keiji Tsuji, Tatehiro Kagawa, Ken Sato, Masaaki Watanabe, et al. Significant association between HLA-B*35:01 and onset of drug-induced liver injury caused by Kampo medicines in Japanese. Hepatology Research. 2022. 53. 5. 440-449
  • Maeda Kazuya, Hajime Takikawa, Mitsuhiko Aiso, Kenji Tsuji, Tatehiro Kagawa, Masaaki Watanabe, Ken Sato, Shotaro Sakisaka, Yoichi Hiasa, Yoshiyuki Takei, et al. Frequency of null genotypes of glutathione S-transferase M1 and T1 in Japanese patients with drug-induced liver injury. Hepatology research : the official journal of the Japan Society of Hepatology. 2022. 52. 10. 882-887
  • Satoshi Takakusagi, Naoto Saito, Takashi Ueno, Takeshi Hatanaka, Masashi Namikawa, Hiroki Tojima, Daichi Takizawa, Atsushi Naganuma, Takashi Kosone, Hirotaka Arai, et al. Changes of esophageal varices in hepatitis C patients after achievement of a sustained viral response by direct-acting antivirals. DEN open. 2022. 2. 1. e11
  • Ken Sato, Yuichi Yamazaki, Yuki Kanayama, Daisuke Uehara, Hiroki Tojima, Takayoshi Suga, Satoru Kakizaki, Naondo Sohara, Norio Horiguchi, Toshio Uraoka. Adolescents with chronic hepatitis C might be good candidates for direct-acting antiviral therapy. Clinical case reports. 2022. 10. 4. e05690
  • Yuichi Yamazaki, Yuki Kanayama, Daisuke Uehara, Takayoshi Suga, Hirohito Tanaka, Hiroki Tojima, Shiko Kuribayashi, Ken Sato, Satoru Kakizaki, Toshio Uraoka. [Liver injury in patients with moderate II COVID-19 who received dexamethasone monotherapy]. Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology. 2022. 119. 4. 332-341
more...
MISC (145):
  • Takehiro Shimizu, Atsushi Naganuma, Ayako Matsui, Tatsuma Murakami, Yuuki Kanamaya, Dan Zennyoji, Takayoshi Suga, Hiroki Tojima, Yuichi Yamazaki, Satoru Kakizaki, et al. A retrospective analysis of pembrolizumab in patients with high microsatellite instability cholangiocarcinoma. ANNALS OF ONCOLOGY. 2022. 33. S518-S518
  • Yuichi Yamazaki, Takashi Ueno, Takeshi Hatanaka, Satoshi Takakusagi, Daichi Takizawa, Atsushi Naganuma, Takashi Kosone, Hiroaki Nakajima, Ken Sato, Satoru Kakizaki, et al. Characteristics of cases of hepatitis E in Gunma prefecture: Small epidemics caused by the same subgenotype 3a strains. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. 2021. 36. 87-88
  • Dan Zennyoji, Ken Sato, Keigo Sato, Takahiro Abe, Masashi Sekiya, Yu Hashimoto, Daisuke Uehara, Takehiro Shimizu, Takayoshi Suga, Hiroko Hosaka, et al. ERCP with a rotary papillotome was facilitated by adjusting monitor position in a patient with situs inversus totalis. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. 2021. 36. 88-89
  • Ken Sato, Takayoshi Suga, Tatsuya Ohyama, Sho Matsui, Takeshi Kobayashi, Hiroki Tojima, Norio Horiguchi, Yuichi Yamazaki, Satoru Kakizaki, Ayaka Nishikido, et al. SIRT1 SIGNALING MAY BE INVOLVED IN ATTENUATION OF LIVER STEATOSIS BY THE SGLT2 INHIBITOR IPRAGLIFLOZIN. HEPATOLOGY. 2019. 70. 1323A-1323A
  • 畑中 健, 柿崎 暁, 長島 多聞, 竝川 昌司, 嶋田 靖, 長沼 篤, 新井 弘隆, 佐藤 賢, 播本 憲史, 調 憲, et al. レンバチニブの至適導入タイミングとは?. 肝臓. 2019. 60. Suppl.2. A704-A704
more...
Lectures and oral presentations  (393):
  • ダクラタスビル・アスナプレビル併用療法不成功例におけるDAAs再治療例の検討
    (肝臓 2019)
  • ペムブロリズマブによる急性肝不全非昏睡型の一例
    (肝臓 2019)
  • 分子標的薬と免疫チェックポイント阻害薬による肝障害(症例報告も可) 当院における免疫チェックポイント阻害薬による肝障害の検討
    (肝臓 2019)
  • 当院における肝臓病教室・患者サロンの現状
    (日本消化器病学会雑誌 2019)
  • C型慢性肝炎難治例に対するDAA再治療の検討
    (日本消化器病学会雑誌 2019)
more...
Education (2):
  • - 1990 Jichi Medical University School of Medicine
  • - 1990 Jichi Medical School Faculty of Medicine
Professional career (1):
  • PhD (Gunma University)
Work history (2):
  • 2000 - 2003 カリフォルニア大学アーバイン校でPhD
  • Gunma University Research Assistant
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page